DD
34
-2
MRK
30
-3
COP
47
17
D
38
-3
V
40
4
ADP
62
3
TSCO
46
-3
WDC
35
3
RF
44
3
CA
10
-6
MPC
33
3
SYF
55
7
CNX
46
-2
VLO
40
4
LRCX
49
7
IRM
41
7
DLTR
36
-2
AFL
49
-3
VMC
60
4
SPG
43
3
DD
34
-2
MRK
30
-3
COP
47
17
D
38
-3
V
40
4
ADP
62
3
TSCO
46
-3
WDC
35
3
RF
44
3
CA
10
-6
MPC
33
3
SYF
55
7
CNX
46
-2
VLO
40
4
LRCX
49
7
IRM
41
7
DLTR
36
-2
AFL
49
-3
VMC
60
4
SPG
43
3
Financhill
Back

Fidelity National Information Services Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
62

FIS
Fidelity National Information Services

Last Price:
$70.21
Seasonality Move:
6.51%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.13
Seasonality Move:
6.73%
Buy
62
Fidelity National Information Services (FIS) is a Buy

Is Fidelity National Information Services a Buy, Sell or Hold?

  • The current Fidelity National Information Services [FIS] share price is $68.12. The Score for FIS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • FIS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FIS Stock Price Chart

What is Fidelity National Information Services's stock price today?

  • The Fidelity National Information Services share price today is $68.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

FIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.34 Sell
Relative Strength Index (14 RSI): 33.4 Sell
Chaikin Money Flow: 2289698 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.67 - 78.47) Sell
Bollinger Bands (100): (74.98 - 88.26) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

FIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.1 Sell
20-day SMA: 70.75 Sell
50-day SMA: 76.47 Sell
200-day SMA: 80.18 Sell
8-day EMA: 69.63 Sell
20-day EMA: 71.57 Sell
50-day EMA: 75.55 Sell
200-day EMA: 77.84 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Fidelity National Information Services Earnings Growth & FIS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.49 per share, and an increase next year of $0.53 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Fidelity National Information Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):